Advertisement
Screener

CASTLE BIOSCIENCES, INC. (CSTL) EBITDA

CASTLE BIOSCIENCES, INC. (CSTL) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $1.00M*; Operating income -$3.07M; Depreciation and amortization $4.07M*.
  • 2026-03-31: Basis Reported; EBITDA -$14.48M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$50,000.00; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$2.99M*; Operating income -$6.80M; Depreciation and amortization $3.82M*.

Complete source-backed ebitda history.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$1.00M*-$3.07M$4.07M*$103.55M0.97%*$8.65M*$15.20M*(m)$14.54M$66.12M$370.00K
2026-03-31Reported-$14.48M(m)(m)(m)-17.30%$12.46M-$22.13M(m)$14.43M$64.90M$109.00K
2025-12-31Reported-$50,000.00(m)(m)(m)-0.06%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$2.99M*-$6.80M$3.82M*$83.04M-3.60%*$14.83M*$22.63M*(m)$12.96M$55.91M$115.00K
2025-06-30Reported-$837.00K*-$4.25M$3.41M*$86.19M-0.97%*$9.26M*$20.82M*(m)$12.79M$58.06M-$4.67M
2025-03-31Reported$1.84M(m)(m)(m)2.09%$4.74M-$6.04M(m)$12.59M$58.62M-$423.00K
2024-12-31Reported$9.82M(m)(m)(m)11.38%(m)(m)(m)(m)(m)(m)
2024-09-30Reported$8.62M*$5.08M$3.54M*$85.78M10.05%*$6.38M*$23.34M*(m)$12.32M$50.50M$6.01M
2024-06-30Reported$8.36M*$5.01M$3.35M*$87.00M9.61%*$5.23M*$24.00M*(m)$14.14M$51.09M-$1.03M
2024-03-31Reported-$2.13M(m)(m)(m)-2.92%$9.15M-$6.83M(m)$13.81M$48.49M$45.00K
2023-12-31Reported-$2.43M(m)(m)(m)-3.68%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$6.47M*-$9.64M$3.17M*$61.49M-10.52%*$2.46M*$5.01M*(m)$12.92M$44.62M$32.00K
2023-06-30Reported-$18.12M*-$21.16M$3.04M*$50.14M-36.13%*$4.04M*-$3.79M*(m)$13.31M$44.68M$16.00K
2023-03-31Reported-$28.63M(m)(m)(m)-68.11%$3.34M-$25.44M(m)$14.39M$46.76M$14.00K
2022-12-31Reported-$19.99M(m)(m)(m)-52.14%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$18.61M*-$21.54M$2.92M*$37.01M-50.29%*$2.04M*-$5.22M*(m)$10.91M$36.63M$0.00
2022-06-30Reported-$1.34M*-$3.97M$2.63M*$34.84M-3.85%*$1.41M*-$9.00M*(m)$11.93M$37.50M-$1.96M
2022-03-31Reported-$22.37M(m)(m)(m)-83.29%$402.00K-$21.43M(m)$10.76M$30.45M$134.00K
2021-12-31Reported-$13.72M(m)(m)(m)-54.79%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$10.72M*-$11.81M$1.09M*$23.48M-45.69%*$927.00K*-$6.13M*(m)$7.50M$22.59M$0.00
2021-06-30Reported-$8.18M*-$8.81M$634.00K*$22.76M-35.93%*$913.00K*-$6.44M*(m)$6.79M$20.82M$5.00K
2021-03-31Reported-$4.05M(m)(m)(m)-17.76%$750.00K-$3.63M$3.03M$5.91M$18.16M$0.00
2020-12-31Reported-$2.87M(m)(m)(m)-16.60%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$3.78M*-$3.90M$119.00K*$15.22M-24.85%*$1.91M*-$2.96M*$2.48M$3.06M$11.70M$0.00
2020-06-30Reported(m)-$645.00K(m)$12.71M(m)$1.76M*$13.50M*$2.15M$2.70M$10.39M$0.00
2020-03-31Reported(m)$1.04M(m)$17.42M(m)$500.00K-$251.00K$2.39M$2.91M$11.08M$0.00
2019-09-30Reported(m)$4.43M(m)$14.77M(m)$166.00K*$752.00K*$1.71M$1.51M$7.12M$0.00
2019-06-30Reported(m)$608.00K(m)$10.74M(m)$180.00K*$482.00K*$1.99M$1.32M$6.82M$0.00
2019-03-31Reported(m)-$322.00K(m)$8.72M(m)$244.00K$1.29M$1.60M$1.39M$6.05M$0.00
2018-09-30Reported(m)-$2.85M(m)$3.71M(m)$87.01K*-$1.88M*$1.35M$1.29M$3.92M$0.00
2018-06-30Reported(m)-$2.67M(m)$3.98M(m)(m)(m)$1.33M$1.16M$4.16M$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$2.04M(m)(m)(m)-0.59%$36.02M$64.35M(m)$51.85M$229.32M-$5.36M
2024-12-31Reported$24.67M(m)(m)(m)7.43%$28.33M$64.87M(m)$52.04M$200.05M$3.32M
2023-12-31Reported-$55.65M(m)(m)(m)-25.32%$13.62M-$5.63M(m)$53.62M$180.15M$101.00K
2022-12-31Reported-$62.31M(m)(m)(m)-45.47%$5.63M-$41.66M(m)$44.90M$143.00M-$1.77M
2021-12-31Reported-$36.67M(m)(m)(m)-38.98%$3.48M-$18.98M$15.82M$29.65M$86.74M-$8.72M
2020-12-31Reported-$6.07M(m)(m)(m)-9.69%$4.75M$9.87M$9.69M$13.26M$48.13M$84.00K
2019-12-31Reported(m)$7.33M(m)$51.87M(m)$937.00K$7.01M$7.31M$7.38M$29.84M$72.00K
2018-12-31Reported(m)-$3.84M(m)$22.79M(m)$277.00K-$12.29M$5.30M$4.85M$16.47M$9.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Personalis, Inc. (PSNL)United States$1.769B-13.30
BIODESIX INC (BDSX)United States$0.312B
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B